Global Multiplexed Diagnostics Market: Overview
This report on the global multiplexed diagnostics market analyzes the current and future scenario of the global market. Rise in private and public funding for genomics and personalized medicine, rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases, and favorable regulatory scenario for new product launch are boosting the growth of the global multiplexed diagnostics market. Multiple Application of multiplexed diagnostics technology, and increasing prevalence of cancer and infectious diseases are some of the factors expected to drive the growth of global multiplexed diagnostics market during the forecast period.
The multiplexed diagnostics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on technology, application, end-user, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises porter’s five forces analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market.
Obtain Report Details @
Global Multiplexed Diagnostics Market: Scope of the Study
Based on technology type, the market has been segmented into Very high density multiplexed assays, High density multiplexed assays, Medium density multiplexed assays, Low density multiplexed assays, and Next generation sequencing assays. High density multiplexed assays and medium density multiplexed assays are projected to be lucrative segments of the multiplexed diagnostics market, due to increasing demand in academic research institutes and pharmaceutical companies. These segments are expected to grow at a highest CAGR rate during forecast period. The market segments have been analyzed based on cost-effectiveness of the technology, prevalence of the diseases, and growing demand for the diagnostic tools. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.
Based on Application type, the Global multiplexed diagnostics market has been segmented into Infectious disease diagnostic, oncology, autoimmune diseases, cardiac diseases, allergies & others which include pregnancy & fertility testing. The market segments have been extensively analyzed based on increase in demand for the disease diagnostic and use in research activities, availability of the technology, and cost efficiency of each technology. Different types of end-users are present in the multiplexed diagnostics market. The end-users are Hospitals, pharmaceutical companies, clinical research organizations, and diagnostic laboratories. Under the end-user segment, the academic research institutes segment accounted for the largest share of the Global multiplexed diagnostics market in 2015 & is expected to dominate the market by 2024.
Global Multiplexed Diagnostics Market: Regional and Competitive Analysis
Geographically, the global Multiplexed Diagnostics Market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, Saudi Arabia, and Rest of Middle East & Africa).
The report also profiles major players in the Global multiplexed diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Agilent Technologies, BioMérieux SA, Bio-Rad Laboratories, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Luminex Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., and Abbott Laboratories.
Fill the form for an exclusive sample of this report @
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.